No profile data available.
ZyVersa Therapeutics, Inc. (ZVSA) is a healthcare company in the urinary system treatment drugs industry, based in Weston, United States, with about 6 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$24.95 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $0. Its market capitalization was $647,673 as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases.
ZyVersa Therapeutics reported $0 in revenue for fiscal year 2025. In Q1 2026 revenue was $0.
$647,673 as of October 9, 2026.
Listed companies of a similar size in the same industry (urinary system treatment drugs) include Cyclerion Therapeutics, Inc. (CYCN), Tvardi Therapeutics, Inc. (TVRD), Nymox Pharmaceutical Corporation (NYMXF), Lipella Pharmaceuticals Inc. (LIPO).